Application for Research Opportunity

Our latest publication in the NEWS:

"Gene Therapy in Rats Reduces Cocaine Use" at Yahoo News

"Gene Therapy in Rats Reduces Cocaine Use" at Washington Post.com

"Gene Therapy in Rats Reduces Cocaine Use" at Forbes.com

"Gene therapy reduces cocaine use in rats" at the United Press

"Gene Therapy in Rats Reduces Cocaine Use" at U.S. News & World Report

"Dopamine Boost Affects Cocaine Use in Rats" at Join Together

Primary Research

• CNS mechanisms of addiction including alcohol, drugs and obesity.

• In-Vivo Imaging: MicroPET, MicroMRI , MicroCT, MRI, PET.

• In-Vitro Imaging: Autoradiography (Beta-Imager).

• Gene therapy techniques in preclinical models of addiction.

• Behavioral Neuropharmacology of dopamine.

• ADHD behavioral genetics.

• CNS mechanisms of stress and depression

• Neuronal injury, regeneration, growth factors.
  

Brookhaven National Lab
P.O. Box 5000
Upton, NY 11973-5000
(631)344-8000

One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE’s Office of Science by Brookhaven Science Associates, a limited-liability company founded by Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit, applied science and technology organization.

Privacy and Security Notice  | Contact Web Services for help